Corvus Pharmaceuticals, Inc. (CRVS)

16.06 -1.78 (-9.98%) USD  |  NASDAQ  |  Mar 05, 16:00
16.40 +0.34 (+2.12%) After-Hours: 05:42
More

Corvus Pharmaceuticals EPS Diluted from Other Gain/Loss (Quarterly)

EPS Diluted from Other Gain/Loss (Quarterly) Chart

View EPS Diluted from Other Gain/Loss (Quarterly) for CRVS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted from Other Gain/Loss (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years

View EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks

View EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. --
Plus Therapeutics, Inc. --
Geron Corp. --
Jaguar Health, Inc. --
Krystal Biotech, Inc. --